Pfizer

NIH launches collaborative program to spur therapeutic development

Friday, May 4, 2012 08:02 AM

The National Institutes of Health (NIH) has unveiled a collaborative program, Discovering New Therapeutic Uses for Existing Molecules, that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients.

More... »

Report: Pharmaceutical market grew by 5.3% in 2011

Friday, April 20, 2012 12:29 PM

Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, found that in 2011, the global pharmaceutical market, in dollar terms, benefitted significantly from positive currency effects.

More... »

INC Research appoints Gaenzle as general counsel

Wednesday, April 11, 2012 03:38 PM

INC Research, a therapeutically focused CRO of Raleigh, N.C., has appointed Christopher L. Gaenzle as its general counsel.  

More... »

Rosenberg joins Esperion Therapeutics as CMO

Monday, April 9, 2012 02:56 PM

Esperion Therapeutics, a Plythmouth, Michigan-based company that discovers and develops novel therapies for the treatment of cardiovascular and metabolic diseases, has appointed Noah Rosenberg, MD, as its chief medical officer.

More... »

Bend Research launches biotherapeutics development initiative

Monday, March 26, 2012 10:52 AM

Bend Research, an independent drug-formulation development and manufacturing company based in Bend, Ore., has launched an initiative to expand its scientific and engineering expertise into biotherapeutics.

More... »

Academic-industry collaboration seeks new drugs, treatments for autism

Monday, March 19, 2012 02:41 PM

An international consortium of scientists led by Roche, King's College London and Autism Speaks is collaborating on one of the largest ever academic-industry research projects, to find new methods for the development of drugs for autism spectrum disorder (ASD), which affects 1% of children worldwide.

More... »

Biocon and Pfizer conclude commercialization agreement

Thursday, March 15, 2012 06:01 AM

India-based biotech Biocon and Pfizer have concluded their alliance to commercialize Biocon's biosimilar versions of insulin and insulin analog products.

More... »

Astellas names Kremer senior VP of global medical affairs

Wednesday, February 29, 2012 06:02 AM

Tokyo-based Astellas Pharma has named Charlotte M. E. Kremer, M.D., senior vice president of Global Medical Affairs (GMA), one of the company's newest organizations.

More... »

Pfizer and Hisun to increase access to high-quality generics

Wednesday, February 22, 2012 02:00 PM

Pfizer and Zhejiang Hisun Pharmaceutical are establishing a joint venture to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

More... »

Sangart appoints three to leadership team

Friday, February 17, 2012 12:43 PM

Sangart, a privately held biopharmaceutical company focused on oxygen-therapeutic agents, has appointed three new members to its executive team.

More... »